Cryptogenic organizing pneumonia history and symptoms
Cryptogenic Organizing Pneumonia Microchapters |
Differentiating Cryptogenic organizing pneumonia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cryptogenic organizing pneumonia history and symptoms On the Web |
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia history and symptoms |
FDA on Cryptogenic organizing pneumonia history and symptoms |
CDC on Cryptogenic organizing pneumonia history and symptoms |
Cryptogenic organizing pneumonia history and symptoms in the news |
Blogs on Cryptogenic organizing pneumonia history and symptoms |
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
Risk calculators and risk factors for Cryptogenic organizing pneumonia history and symptoms |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
History and Symptoms
History
Patients with cryptogenic organizing pneumonia may have a positive history of:[1][2]
- Connective tissue diseases
- Drugs intake e.g, Acebutolol, Amiodarone, Amphotericin B, Atorvastatin, Azacytidine, Azathioprine.
- History of malignancy
- History of other interstitial lung disease
Common Symptoms
Common symptoms of cryptogenic organizing pneumonia include:[3][4]
- Continuous dry cough
- Shortness of breath
- Fever
- Generalized fatigue
- Significant Weight loss
Less Common Symptoms
Less common symptoms of cryptogenic organizing pneumonia include:
References
- ↑ Alasaly K, Muller N, Ostrow DN, Champion P, FitzGerald JM (July 1995). "Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature". Medicine (Baltimore). 74 (4): 201–11. PMID 7623655.
- ↑ Yoo JW, Song JW, Jang SJ, Lee CK, Kim MY, Lee HK, Jegal Y, Kim DS (May 2011). "Comparison between cryptogenic organizing pneumonia and connective tissue disease-related organizing pneumonia". Rheumatology (Oxford). 50 (5): 932–8. doi:10.1093/rheumatology/keq410. PMID 21169342.
- ↑ Henkler G, Klotzbach M, Koch H, Müller W, Richter J (October 1979). "[Progress in the area of drug development. 12]". Pharmazie (in German). 34 (10): 609–34. PMID 396533.
- ↑ Lazor R, Vandevenne A, Pelletier A, Leclerc P, Court-Fortune I, Cordier JF (August 2000). "Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P)". Am. J. Respir. Crit. Care Med. 162 (2 Pt 1): 571–7. doi:10.1164/ajrccm.162.2.9909015. PMID 10934089.